Venlafaxine More Effectively Treats Symptoms of Major Depressive Disorder After Menopause Than Fluoxetine

To date, there has not been proven evidence for serotonin-norepinephrine reuptake inhibitors over selective serotonin reuptake inhibitors in postmenopausal patients with major depressive disorder. Consequently, study researchers aimed to compare the efficacy and safety of venlafaxine vs fluoxetine in the treatment of postmenopausal MDD.

Next post in Anxiety